Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,546 | 0 | 1,000 | 5,000 | 15,000 |
| Gross Profit | 1,546 | N/A | 1,000 | 5,000 | 15,000 |
| Operating Expenses | 63,686 | 42,102 | 62,098 | 64,642 | 58,073 |
| Operating Income | -62,140 | -42,102 | -61,098 | -59,642 | -43,073 |
| Interest Expense | 3,838 | 3,581 | 2,554 | 0 | 0 |
| Other Income | 2,920 | 4,164 | 3,967 | 1,254 | 220 |
| Pre-tax Income | -63,058 | -41,519 | -59,685 | -58,388 | -42,853 |
| Net Income Continuous | -63,058 | -41,519 | -59,685 | -58,388 | -42,853 |
| Net Income | $-63,058 | $-41,519 | $-59,685 | $-58,388 | $-42,853 |
| EPS Basic Total Ops | -0.75 | -0.67 | -1.39 | -1.38 | -1.02 |
| EPS Basic Continuous Ops | -0.75 | -0.67 | -1.39 | -1.38 | -1.02 |
| EPS Diluted Total Ops | -0.75 | -0.67 | -1.39 | -1.38 | -1.02 |
| EPS Diluted Continuous Ops | -0.75 | -0.67 | -1.39 | -1.38 | -1.02 |
| EPS Diluted Before Non-Recurring Items | -0.75 | -0.67 | -1.39 | -1.38 | -1.02 |
| EBITDA(a) | $-62,026 | $-41,997 | $-61,006 | $-59,553 | $-42,980 |